Covered recipient · General Payments record
MAIA ENTROPO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$3,551.57
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $315.24 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $145.04 | 9 |
| UCB, Inc. | $40.44 | 2 |
| E.R. Squibb & Sons, L.L.C. | $38.08 | 2 |
| Janssen Biotech, Inc. | $35.47 | 2 |
| Acerta Pharma LLC | $24.49 | 1 |
| Aurinia Pharma U.S., Inc. | $17.84 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.87 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074989 | CMS |
| ABBVIE INC. | $11.32 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074991 | CMS |
| ABBVIE INC. | $15.63 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074993 | CMS |
| ABBVIE INC. | $22.45 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074995 | CMS |
| ABBVIE INC. | $22.07 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074997 | CMS |
| ABBVIE INC. | $15.32 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074999 | CMS |
| ABBVIE INC. | $7.02 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107075001 | CMS |
| ABBVIE INC. | $20.82 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107075003 | CMS |
| ABBVIE INC. | $20.54 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107075005 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.49 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105509048 | CMS |
| Aurinia Pharma U.S., Inc. | $17.84 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150696650 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.50 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101624586 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.58 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101624598 | CMS |
| Janssen Biotech, Inc. | $16.56 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078338819 | CMS |
| Janssen Biotech, Inc. | $18.91 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078338590 | CMS |
| Novartis Pharmaceuticals Corporation | $13.88 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086789307 | CMS |
| UCB, Inc. | $15.78 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143335513 | CMS |
| UCB, Inc. | $24.66 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143335517 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.